Bernadett Farkas

Szeged, CS, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Predictive value of iron deficiency anaemia on the one-year disease course in inflammatory bowel disease patients in clinical and biochemical remission.

Predictive value of iron deficiency anaemia on the one-year disease course in inflammatory bowel disease patients in clinical and biochemical remission.

Journal: Scandinavian journal of gastroenterology

Published: May 12, 2026

The Role of Physical Activity and Physiotherapists in the Management of Inflammatory Bowel Disease: A Nationwide Cross-Sectional Survey.

The Role of Physical Activity and Physiotherapists in the Management of Inflammatory Bowel Disease: A Nationwide Cross-Sectional Survey.

Journal: Journal of clinical medicine

Published: March 01, 2026

Evaluation of Long-Term Outcomes of Crohn's Disease Complicated by Intra-Abdominal Abscess: A Retrospective International Cohort Study.

Evaluation of Long-Term Outcomes of Crohn's Disease Complicated by Intra-Abdominal Abscess: A Retrospective International Cohort Study.

Journal: Journal of clinical medicine

Published: February 17, 2026

Impact of Newly Introduced Population-Based Screening and the COVID-19 Pandemic on Colorectal Cancer Incidence and Characteristics: A Retrospective Cohort Study.

Impact of Newly Introduced Population-Based Screening and the COVID-19 Pandemic on Colorectal Cancer Incidence and Characteristics: A Retrospective Cohort Study.

Journal: Clinical and translational gastroenterology

Published: September 16, 2025

Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study.

Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study.

Journal: Biologics : targets & therapy

Published: August 11, 2025

A narrative review on the frequency, pathophysiology and management of bowel urgency associated with ulcerative colitis.

A narrative review on the frequency, pathophysiology and management of bowel urgency associated with ulcerative colitis.

Journal: Best practice & research. Clinical gastroenterology

Published: August 08, 2025

The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

Journal: Journal of Crohn's & colitis

Published: June 10, 2025

Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study.

Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study.

Journal: Expert opinion on biological therapy

Published: May 10, 2025

Upadacitinib Is Associated With Better Clinical and Biochemical Outcomes Than Tofacitinib in Refractory, Moderate-to-Severe Ulcerative Colitis.

Upadacitinib Is Associated With Better Clinical and Biochemical Outcomes Than Tofacitinib in Refractory, Moderate-to-Severe Ulcerative Colitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 23, 2025

Short- and longevity outcome of cyclosporin rescue therapy in severe ulcerative colitis refractory to intravenous corticosteroid treatment.

Short- and longevity outcome of cyclosporin rescue therapy in severe ulcerative colitis refractory to intravenous corticosteroid treatment.

Journal: Therapeutic advances in gastroenterology

Published: February 06, 2025

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study.

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study.

Journal: Journal of clinical medicine

Published: November 14, 2024

Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.

Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.

Journal: Biomedicines

Published: July 19, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026